Literature DB >> 20376080

Elevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in AML.

J A Pulikkan1, V Dengler, A A Peer Zada, A Kawasaki, M Geletu, Z Pasalic, S K Bohlander, A Ryo, D G Tenen, G Behre.   

Abstract

The transcription factor CCAAT enhancer-binding protein alpha (C/EBPalpha) has an important role in granulopoiesis. The tumor suppressor function of C/EBPalpha is shown by the findings that loss of expression or function of C/EBPalpha in leukemic blasts contributes to a block in myeloid cell differentiation and to leukemia. C/EBPalpha mutations are found in around 9% of acute myeloid leukemia (AML) patients. The mechanism by which the mutant form of C/EBPalpha (C/EBPalpha-p30) exerts a differentiation block is not well understood. By using a proteomic screen, we have recently reported PIN1 as a target of C/EBPalpha-p30 in AML. In the present study, we show that C/EBPalpha-p30 induces PIN1 expression. We observed elevated PIN1 expression in leukemic patient samples. Induction of C/EBPalpha-p30 results in recruitment of E2F1 in the PIN1 promoter. We show that the inhibition of PIN1 leads to myeloid differentiation in primary AML blasts with C/EBPalpha mutations. Overexpression of PIN1 in myeloid cells leads to block of granulocyte differentiation. We also show that PIN1 increases the stability of the c-Jun protein by inhibiting c-Jun ubiquitination, and c-Jun blocks granulocyte differentiation mediated by C/EBPalpha. Our data suggest that the inhibition of PIN1 could be a potential strategy of treating AML patients with C/EBPalpha mutation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20376080      PMCID: PMC2923485          DOI: 10.1038/leu.2010.37

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  47 in total

1.  Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis.

Authors:  J F Rippmann; S Hobbie; C Daiber; B Guilliard; M Bauer; J Birk; H Nar; P Garin-Chesa; W J Rettig; A Schnapp
Journal:  Cell Growth Differ       Date:  2000-07

2.  E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo.

Authors:  B T Porse; X Xu; B Lindberg; U M Wewer; L Friis-Hansen; C Nerlov
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

3.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

4.  Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.

Authors:  G M Wulf; A Ryo; G G Wulf; S W Lee; T Niu; V Petkova; K P Lu
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

5.  Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes.

Authors:  Yih-Cherng Liou; Akihide Ryo; Han-Kuei Huang; Pei-Jung Lu; Roderick Bronson; Fumihiro Fujimori; Takafumi Uchida; Tony Hunter; Kun Ping Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

6.  Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.

Authors:  T Pabst; B U Mueller; P Zhang; H S Radomska; S Narravula; S Schnittger; G Behre; W Hiddemann; D G Tenen
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

Review 7.  Jun, the oncoprotein.

Authors:  P K Vogt
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

8.  c-Myc is a critical target for c/EBPalpha in granulopoiesis.

Authors:  L M Johansen; A Iwama; T A Lodie; K Sasaki; D W Felsher; T R Golub; D G Tenen
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

9.  Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias.

Authors:  Adrian F Gombart; Wolf-K Hofmann; Seiji Kawano; Seisho Takeuchi; Utz Krug; Scott H Kwok; Renee J Larsen; Hiroya Asou; Carl W Miller; Dieter Hoelzer; H Phillip Koeffler
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

10.  Investigation of C/EBPalpha function in human (versus murine) myelopoiesis provides novel insight into the impact of CEBPA mutations in acute myelogenous leukemia (AML).

Authors:  B Niebuhr; G B Iwanski; M Schwieger; S Roscher; C Stocking; J Cammenga
Journal:  Leukemia       Date:  2008-11-20       Impact factor: 11.528

View more
  35 in total

1.  Connectedness of PPI network neighborhoods identifies regulatory hub proteins.

Authors:  Andrew D Fox; Benjamin J Hescott; Anselm C Blumer; Donna K Slonim
Journal:  Bioinformatics       Date:  2011-03-02       Impact factor: 6.937

2.  Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation.

Authors:  P Rajbhandari; K A Schalper; N M Solodin; S J Ellison-Zelski; K Ping Lu; D L Rimm; E T Alarid
Journal:  Oncogene       Date:  2013-04-01       Impact factor: 9.867

Review 3.  Prolyl isomerase Pin1 in cancer.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Cell Res       Date:  2014-08-15       Impact factor: 25.617

4.  Inhibition of Casein Kinase 2 Disrupts Differentiation of Myeloid Cells in Cancer and Enhances the Efficacy of Immunotherapy in Mice.

Authors:  Ayumi Hashimoto; Chan Gao; Jerome Mastio; Andrew Kossenkov; Scott I Abrams; Ashok V Purandare; Heshani Desilva; Susan Wee; John Hunt; Maria Jure-Kunkel; Dmitry I Gabrilovich
Journal:  Cancer Res       Date:  2018-08-23       Impact factor: 12.701

5.  PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells.

Authors:  Kwang Youl Lee; Jeong Woon Lee; Hyun Jeong Nam; Jeong-Hyun Shim; Youngsup Song; Keon Wook Kang
Journal:  Mol Cells       Date:  2011-05-11       Impact factor: 5.034

Review 6.  C/EBPα deregulation as a paradigm for leukemogenesis.

Authors:  J A Pulikkan; D G Tenen; G Behre
Journal:  Leukemia       Date:  2017-07-19       Impact factor: 11.528

7.  The role of PIN1 on odontogenic and adipogenic differentiation in human dental pulp stem cells.

Authors:  Young-Man Lee; Seung-Yun Shin; Seong-Suk Jue; Il-Keun Kwon; Eun-Hee Cho; Eui-Sic Cho; Sang-Hyuk Park; Eun-Cheol Kim
Journal:  Stem Cells Dev       Date:  2013-12-24       Impact factor: 3.272

8.  Pin1 interacts with the Epstein-Barr virus DNA polymerase catalytic subunit and regulates viral DNA replication.

Authors:  Yohei Narita; Takayuki Murata; Akihide Ryo; Daisuke Kawashima; Atsuko Sugimoto; Teru Kanda; Hiroshi Kimura; Tatsuya Tsurumi
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

9.  Pin1-mediated Runx2 modification is critical for skeletal development.

Authors:  Won-Joon Yoon; Rabia Islam; Young-Dan Cho; Kyung-Mi Woo; Jeong-Hwa Baek; Takafumi Uchida; Toshihisa Komori; Andre van Wijnen; Janet L Stein; Jane B Lian; Gary S Stein; Je-Yong Choi; Suk-Chul Bae; Hyun-Mo Ryoo
Journal:  J Cell Physiol       Date:  2013-12       Impact factor: 6.384

10.  The presence of C/EBPα and its degradation are both required for TRIB2-mediated leukaemia.

Authors:  C O'Connor; F Lohan; J Campos; E Ohlsson; M Salomè; C Forde; R Artschwager; R M Liskamp; M R Cahill; P A Kiely; B Porse; K Keeshan
Journal:  Oncogene       Date:  2016-03-21       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.